July 26, 2024Open Access

Localized incompletely resected standard risk rhabdomyosarcoma in children and adolescents: Results from the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 trial

Key Points

Key points are not available for this paper at this time.

Abstract

The authors report the prospective evaluation of reduced dose alkylator chemotherapy combined with radiotherapy for European Pediatric Soft Tissue Sarcoma Study Group (EpSSG) standard risk nonalveolar rhabdomyosarcoma (NA-RMS).

Read Full Paperexternally

问 AI

Bookmark

View Full Paper

Cite This Study

Mandeville et al. (Fri,) studied this question.

synapsesocial.com/papers/68e5ee7cb6db643587582aba https://doi.org/https://doi.org/10.1002/cncr.35497

问 AI

Bookmark

View Full Paper